Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2024-11-03 20:16:59]
5 Years H Index
6
Impact Factor (IF)
0.06
5 Years IF
0.04
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
2012 0 0.52 0 0 7 7 0 0 0 0 0 0 0.22
2014 0 0.55 0 0 8 15 11 0 7 7 0 0 0.23
2015 0 0.55 0 0 1 16 0 0 8 15 0 0 0.23
2016 0.22 0.53 0.11 0.13 98 114 82 12 12 9 2 16 2 11 91.7 10 0.1 0.21
2017 0.15 0.54 0.15 0.16 119 233 82 34 46 99 15 114 18 30 88.2 11 0.09 0.22
2018 0.14 0.55 0.16 0.14 134 367 77 60 106 217 30 226 31 52 86.7 22 0.16 0.24
2019 0.09 0.57 0.16 0.08 131 498 57 78 184 253 24 360 28 68 87.2 33 0.25 0.23
2020 0.11 0.68 0.12 0.09 130 628 39 76 260 265 28 483 45 51 67.1 10 0.08 0.32
2021 0.08 0.81 0.1 0.07 124 752 29 78 338 261 22 612 45 48 61.5 9 0.07 0.3
2022 0.08 0.86 0.1 0.07 118 870 13 91 429 254 21 638 42 49 53.8 3 0.03 0.26
2023 0.06 0.92 0.04 0.04 85 955 8 42 471 242 15 637 25 19 45.2 5 0.06 0.27
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K ; Luo, Yuan. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

8
22018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E ; Watson, Sarah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

7
32014Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David ; Callahan, Alison ; Low, Yen . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

7
42017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled ; Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

7
52016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

6
62016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen ; Sarker, Abeed . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

6
72016The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence ; Rolfes, Lean. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

6
82017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I ; Caster, Ola. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

6
92016Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. (2016). Curtain, Colin M ; Angamo, Mulugeta Tarekegn ; Ke, LU ; Chalmers, Leanne. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0444-7.

Full description at Econpapers || Download paper

5
102016Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Hughes, Carmel M ; Cadogan, Cathal A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5.

Full description at Econpapers || Download paper

5
112019Patient Registries: An Underused Resource for Medicines Evaluation. (2019). PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel Nogueras ; Castillon, Mireia ; Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00848-9.

Full description at Econpapers || Download paper

5
122016Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Olsson, Sten ; Pal, Shanthi N ; Hoekman, Jarno ; Alexander, ; Bruin, Marieke L ; Ampadu, Haggar H ; Sartori, Daniele. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4.

Full description at Econpapers || Download paper

5
132016A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A ; Grampp, Gustavo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4.

Full description at Econpapers || Download paper

4
142019Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Patterson, Olga V ; Duvall, Scott L ; Alba, Patrick R ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y.

Full description at Econpapers || Download paper

4
152017Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Arlett, Peter ; Genov, Georgy ; Haerry, David ; Houez, Francois ; Slattery, Jim ; Candore, Gianmario ; Banovac, Marin . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1.

Full description at Econpapers || Download paper

4
162018Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan ; Comfort, Shaun. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7.

Full description at Econpapers || Download paper

4
172016Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Pratt, Nicole L ; Roughead, Elizabeth E ; Ellett, Lisa Kalisch ; Wahab, Izyan A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8.

Full description at Econpapers || Download paper

4
182016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Matos, Cristiano ; Hunsel, Florence ; Harmark, Linda. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

4
192019Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

4
202019MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Hogan, William R ; Gong, Yan ; Bian, Jiang ; Yang, XI. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0.

Full description at Econpapers || Download paper

4
212018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah ; Duong, Mai. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

4
222016The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Smith, Meredith Y ; Benattia, Isma . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

4
232019Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Rundensteiner, Elke A ; Sen, Cansu ; Kakar, Tabassum ; Qin, Xiao ; Wunnava, Susmitha. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9.

Full description at Econpapers || Download paper

4
242017Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). , Peter ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x.

Full description at Econpapers || Download paper

4
252016Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G ; Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper<

4
262019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Vries, Sieta T ; Antoni, ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. (2016). Newbould, Victoria ; Goedecke, Thomas ; Ord, Kathryn ; Arlett, Peter ; Brosch, Sabine. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0410-4.

Full description at Econpapers || Download paper

3
282018All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population. (2018). Sclar, David A ; Fairman, Kathleen A ; Peckham, Alyssa M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0595-1.

Full description at Econpapers || Download paper

3
292019The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. (2019). Mugelli, Alessandro ; Clavenna, Antonio ; Corrao, Giovanni ; Moretti, Ugo ; Carnovale, Carla ; Mantovani, Lorenzo ; Lucenteforte, Ersilia ; Capuano, Annalisa ; Vannacci, Alfredo ; Leoni, Olivia ; Cantarutti, Anna ; Traversa, Giuseppe ; Leone, Roberto ; Beghi, Ettore ; Tettamanti, Mauro ; Lapi, Francesco ; Barone-Adesi, Francesco ; Sultana, Janet ; Kirchmayer, Ursula ; Gini, Rosa ; Rea, Federico ; Ingrasciotta, Ylenia ; Trifiro, Gianluca ; Rafaniello, Concita ; Franchi, Matteo ; Poluzzi, Elisabetta ; Ferrajolo, Carmen ; Naldi, Luigi ; Dellagiovanna, Mirosa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-073
302017Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2.

Full description at Econpapers || Download paper

3
312017An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Singh, Sonal ; Segal, Jodi B ; Marimuthu, Sathiya Priya ; Iyer, Geetha . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1.

Full description at Econpapers || Download paper

3
322018Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature. (2018). Pers, Yves-Marie ; Jorgensen, Christian ; Vernhet, Helene ; Roubille, Franois ; Chatre, Clotilde. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0689-4.

Full description at Econpapers || Download paper

3
332018Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. (2018). Vroman, Benoit ; Tcherny-Lessenot, Stephanie ; Noren, Niklas G ; Maskell, Simon ; Lerch, Magnus ; Kurzinger, Marie-Laure ; Dietrich, Juergen ; Caster, Ola ; Stekelenborg, John ; Wisniewski, Antoni. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0699-2.

Full description at Econpapers || Download Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Popko, Leszek ; Bowling, Rich ; Koneswarakantha, Bjorn ; Barmaz, Yves ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4.

Full description at Econpapers || Download paper

3
352016Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis. (2016). Lieftucht, Alfons ; Sugiyama, Keiji ; Buyse, Hubert ; Holl, Katsiaryna ; Mckenna, Michael ; Ledent, Edouard . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0376-7.

Full description at Econpapers || Download paper

3
362019The Role of European Patient Organizations in Pharmacovigilance. (2019). Hunsel, Florence ; Weits, Gerda ; Matos, Cristiano. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0748-x.

Full description at Econpapers || Download paper

3
372017Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention. (2017). Zeldis, Jerome B ; Sheehan, Paul ; Houn, Florence ; Freeman, John ; Bwire, Robert ; Brandenburg, Nancy A. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0501-2.

Full description at Econpapers || Download paper

3
382018Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases. (2018). Bate, Andrew ; Hauben, Manfred ; Whalen, ED. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0640-8.

Full description at Econpapers || Download paper

3
392017Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences. (2017). Andri, Adriana ; Ipi, Ivana ; Montero, Dolores ; Coleman, Anna Marie ; Baldelli, Ilaria ; Cupelli, Amelia ; PEter, ; Vries, Sieta T ; Denig, Petra ; Ahlqvist-Rastad, Jane ; Wennberg, Annika . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0535-0.

Full description at Econpapers || Download paper

3
402018From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Bate, Andrew ; Sultana, Janet ; Trifiro, Gianluca. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4.

Full description at Econpapers || Download paper

3
412021Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices. (2021). Taylor, Robert ; Leonard, Eileen ; Cherry, Mark ; Mishalov, Ellen ; Savage, Elizabeth ; Dobracki, Pawel ; Kjoersvik, Oeystein ; Huysentruyt, Kristof ; Abatemarco, Danielle ; Patel, Bhavin. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2.

Full description at Econpapers || Download paper

3
422016Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip ; Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3.

Full description at Econpapers || Download paper

3
432017Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review. (2017). Ashcroft, Darren M ; Keers, Richard N ; Alshehri, Ghadah H. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0557-7.

Full description at Econpapers || Download paper

3
442017Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. (2017). Bereznicki, Luke R ; Connolly, Michael ; Peterson, Gregory M ; Curtain, Colin ; Chalmers, Leanne ; Nair, Nibu Parameswaran . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0528-z.

Full description at Econpapers || Download paper

3
452019Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Widdowson, Mark ; Abatemarco, Danielle ; Mockute, Ruta ; Tetarenko, Niki ; Assuncao, Bruno ; Mingle, Edward ; Cicirello, Salvatore ; Danysz, Karolina ; Desai, Sameen. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z.

Full description at Econpapers || Download paper

3
462020Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Steinke, Douglas ; Alqenae, Fatema A. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3.

Full description at Econpapers || Download paper

3
472017Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature. (2017). Bouder, Frederic ; Way, Dominic ; Blazsin, Hortense ; Lofstedt, Ragnar. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0466-1.

Full description at Econpapers || Download paper

3
482019Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance. (2019). Dal, Gerald J ; Wu, Eileen ; Muoz, Monica A ; Kortepeter, Cindy M ; Kalra, Dipti ; Harinstein, Lisa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-0759-7.

Full description at Econpapers || Download paper

3
492020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

3
502016National ADR Monitoring System in China. (2016). Ye, Xiaofei ; Hou, Yongfang ; Li, Xinling ; Wu, Guizhi . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0446-5.

Full description at Econpapers || Download paper

3
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K ; Luo, Yuan. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

4
22021Validating Intelligent Automation Systems in Pharmacovigilance: Insights from Good Manufacturing Practices. (2021). Taylor, Robert ; Leonard, Eileen ; Cherry, Mark ; Mishalov, Ellen ; Savage, Elizabeth ; Dobracki, Pawel ; Kjoersvik, Oeystein ; Huysentruyt, Kristof ; Abatemarco, Danielle ; Patel, Bhavin. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:3:d:10.1007_s40264-020-01030-2.

Full description at Econpapers || Download paper

3
32019Aim and Design of pREGnant, the Dutch Pregnancy Drug Register. (2019). Puijenbroek, Eugene ; Roeleveld, Nel ; Kant, Agnes ; Winkel, Bernke ; Vorstenbosch, Saskia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0722-7.

Full description at Econpapers || Download paper

3
42019Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0). (2019). Yu, Hong ; Liu, Weisong ; Jagannatha, Abhyuday. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0762-z.

Full description at Econpapers || Download paper

3
52019MADEx: A System for Detecting Medications, Adverse Drug Events, and Their Relations from Clinical Notes. (2019). Wu, Yonghui ; Hogan, William R ; Gong, Yan ; Bian, Jiang ; Yang, XI. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0761-0.

Full description at Econpapers || Download paper

2
62017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled ; Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

2
72016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen ; Sarker, Abeed . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

2
82016Post-Marketing Benefit–Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis. (2016). Lieftucht, Alfons ; Sugiyama, Keiji ; Buyse, Hubert ; Holl, Katsiaryna ; Mckenna, Michael ; Ledent, Edouard . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0376-7.

Full description at Econpapers || Download paper

2
92019A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding. (2019). Frauman, Albert ; Aminian, Parnaz ; Keith, Claire ; Liew, David ; McMaster, Christopher. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-018-00794-y.

Full description at Econpapers || Download paper

2
102016A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A ; Grampp, Gustavo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4.

Full description at Econpapers || Download paper

2
112021Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database. (2021). Munoz, Flor M ; Eckert, Linda O ; Burrell, Timothy A ; Sheng, Minya ; Hobbi, Shayan ; Fingar, Kathryn ; Wong, Hui Lee ; Moll, Keran ; Anderson, Steven ; Shoaibi, Azadeh ; Baer, Bethany. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:11:d:10.1007_s40264-021-01113-8.

Full description at Econpapers || Download paper<

2
122017Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals. (2017). Bereznicki, Luke R ; Connolly, Michael ; Peterson, Gregory M ; Curtain, Colin ; Chalmers, Leanne ; Nair, Nibu Parameswaran . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0528-z.

Full description at Econpapers || Download paper

2
132019Correction to: A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding. (2019). Frauman, Albert ; Aminian, Parnaz ; Keith, Claire ; Liew, David ; McMaster, Christopher. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00820-7.

Full description at Econpapers || Download paper

2
142019Adverse Drug Event Detection from Electronic Health Records Using Hierarchical Recurrent Neural Networks with Dual-Level Embedding. (2019). Kong, Xiangnan ; Rundensteiner, Elke A ; Sen, Cansu ; Kakar, Tabassum ; Qin, Xiao ; Wunnava, Susmitha. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0765-9.

Full description at Econpapers || Download paper

2
152018Time Series Disturbance Detection for Hypothesis-Free Signal Detection in Longitudinal Observational Databases. (2018). Bate, Andrew ; Hauben, Manfred ; Whalen, ED. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0640-8.

Full description at Econpapers || Download paper

2
162022Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity. (2022). Aronson, Jeffrey K ; Anton, Christopher ; Stevens, Richard J ; Ferner, Robin E. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:2:d:10.1007_s40264-021-01138-z.

Full description at Econpapers || Download paper

2
172017Causality Assessment in Pharmacovigilance: Still a Challenge. (2017). Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-017-0509-2.

Full description at Econpapers || Download paper

2
182016Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. (2016). Ryan, Cristin ; Hughes, Carmel M ; Cadogan, Cathal A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0378-5.

Full description at Econpapers || Download paper

2
192020Assessing the Safety of COVID-19 Vaccines: A Primer. (2020). Petousis-Harris, Helen. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:12:d:10.1007_s40264-020-01002-6.

Full description at Econpapers || Download paper

2
202020Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review. (2020). Keers, Richard N ; Steinke, Douglas ; Alqenae, Fatema A. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:6:d:10.1007_s40264-020-00918-3.

Full description at Econpapers || Download paper

2
212017Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences. (2017). Andri, Adriana ; Ipi, Ivana ; Montero, Dolores ; Coleman, Anna Marie ; Baldelli, Ilaria ; Cupelli, Amelia ; PEter, ; Vries, Sieta T ; Denig, Petra ; Ahlqvist-Rastad, Jane ; Wennberg, Annika . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0535-0.

Full description at Econpapers || Download paper

2
222019Detecting Adverse Drug Events with Rapidly Trained Classification Models. (2019). Patterson, Olga V ; Duvall, Scott L ; Alba, Patrick R ; Peterson, Kelly S ; Chapman, Alec B. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:1:d:10.1007_s40264-018-0763-y.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 15
YearTitle
2023Validation of an ICD-9-Based Algorithm to Identify Stillbirth Episodes from Medicaid Claims Data. (2023). Bird, Steven T ; Thai, Thuy N ; Smolinski, Nicole E ; Nduaguba, Sabina O ; Winterstein, Almut G ; Rasmussen, Sonja A. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01287-3.

Full description at Econpapers || Download paper

2023
2023.

Full description at Econpapers || Download paper

2023Intelligent automation implementation and corporate sustainability performance: The enabling role of corporate social responsibility strategy. (2023). Yadegaridehkordi, Elaheh ; Mubarak, Muhammad Faraz ; Foroughi, Behzad ; Iranmanesh, Mohammad ; Asadi, Shahla ; Ghobakhloo, Morteza. In: Technology in Society. RePEc:eee:teinso:v:74:y:2023:i:c:s0160791x23001069.

Full description at Econpapers || Download paper

2023
2023COVID-19 off-label uses of medicines: the role of civil liability and regulation. (2023). Parziale, Andrea. In: The Geneva Papers on Risk and Insurance - Issues and Practice. RePEc:pal:gpprii:v:48:y:2023:i:3:d:10.1057_s41288-023-00302-z.

Full description at Econpapers || Download paper

2023The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed. (2023). Elhawary, Mohamed A ; Ndagije, Helen Byomire ; Rostom, Hadir ; Caro, Angela ; Bahri, Priya ; Alkhakany, Mayada ; Younus, Manal M. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:7:d:10.1007_s40264-023-01313-4.

Full description at Econpapers || Download paper

2023Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose. (2023). Schmikli, Sandor ; Dureau-Pournin, Caroline ; Klungel, Olaf H ; Thurin, Nicolas H ; Shakir, Saad ; Hunsel, Florence ; Giovanazzi, Alexia ; Raethke, Monika ; Luxi, Nicoletta ; Trifiro, Gianluca ; Sabbe, Martine ; Clercq, Evelien ; Skvrce, Nikica Miroevi ; Kovai, Barbara ; Sturkenboom, Miriam ; Mentzer, Dirk. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:4:d:10.1007_s40264-023-01281-9.

Full description at Econpapers || Download Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience. (2023). Hunsel, Florence ; Kant, Agnes ; Puijenbroek, Eugene ; Scholl, Joep ; Oosterhuis, Ingrid. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:1:d:10.1007_s40264-022-01253-5.

Full description at Econpapers || Download paper

2023Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR Trial. (2023). Bilton, Rebecca L ; Andrade, Andre Q ; Roughead, Elizabeth E ; Dorj, Gerel ; Widagdo, Imaina ; Kalisch, Lisa M ; Bereznicki, Luke ; Nair, Nibu Parameswaran ; Kelly, Thu-Lan ; Pratt, Nicole L ; Lim, Renly ; Whitehouse, Joseph ; Rowett, Debra. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01299-z.

Full description at Econpapers || Download Identification of SMEs in the Critical Factors of an IS Backup System Using a Three-Stage Advanced Hybrid MDM–AHP Model. (2023). Chen, Xuan-Han ; Hung, Ying-Hsun ; Lin, Yu-Sheng ; Chou, Jerome Chih-Lung. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:4:p:3516-:d:1068419.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Provision and Characterization of a Corpus for Pharmaceutical, Biomedical Named Entity Recognition for Pharmacovigilance: Evaluation of Language Registers and Training Data Sufficiency. (2023). Kazzer, Philipp ; Dietrich, Jurgen. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:8:d:10.1007_s40264-023-01322-3.

Full description at Econpapers || Download paper

2023Food Proteins: Potential Resources. (2023). Babich, Olga ; Michaud, Philippe ; Prosekov, Alexander ; Kashirskikh, Egor ; Ivanova, Svetlana ; Kalashnikova, Olga ; Sukhikh, Stanislav ; Dolganyuk, Vyacheslav. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:7:p:5863-:d:1109512.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2023

YearCiting document
2023
2023Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities. (2023). Jouquelet-Royer, Corinne ; Frise, Sarah ; Davis, Kourtney ; Bauchau, Vincent ; Wilkins, Jamie. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:4:d:10.1007_s40264-023-01290-8.

Full description at Econpapers || Download paper

2023Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events. (2023). Alkabbani, Wajd ; Gamble, John-Michael. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:5:d:10.1007_s40264-023-01293-5.

Full description at Econpapers || Download paper

2023Authors’ Reply to Juergen O Kirchner’s Comment on “Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project”. (2023). , Miriam ; Weibel, Daniel ; Willame, Corinne. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:8:d:10.1007_s40264-023-01311-6.

Full description at Econpapers || Download paper

2023Comment on: “Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System”. (2023). Tuccori, Marco ; Convertino, Irma ; Ferraro, Sara ; Bonaso, Marco ; Valdiserra, Giulia ; Cappello, Emiliano. In: Drug Safety. RePEc:spr:drugsa:v:46:y:2023:i:9:d:10.1007_s40264-023-01330-3.

Full description at Econpapers || Download paper

Recent citations received in 2022

YearCiting document
2022Conundrum of Clinical QTc Monitoring. (2022). Malik, Marek. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:10:d:10.1007_s40264-022-01229-5.

Full description at Econpapers || Download paper

2022Authors’ Response to Yoshihiro Noguchi’s Comment on: “A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)”. (2022). Boyce, Richard D ; Tan, Malinda S ; Horn, John ; Gomez-Lumbreras, Ainhoa ; Villa-Zapata, Lorenzo ; Malone, Daniel C. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:12:d:10.1007_s40264-022-01239-3.

Full description at Econpapers || Download paper

2022Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting. (2022). Alkabbani, Wajd ; Gamble, John-Michael. In: Drug Safety. RePEc:spr:drugsa:v:45:y:2022:i:7:d:10.1007_s40264-022-01192-1.

Full description at Econpapers || Download paper

Recent citations received in 2021

YearCiting document
2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021The Effectiveness and Value of Written Medicine Information Across Asia and Africa: Systematic Review. (2021). Krska, Janet ; Corlett, Sarah A ; Nualdaisri, Pitchaya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:12:d:10.1007_s40264-021-01114-7.

Full description at Econpapers || Download paper

2021Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using. (2021). Numan, Syed ; Kaluza, Karolina ; Trumbo, Henry ; Goodnough, Lawrence T. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:5:d:10.1007_s40264-021-01059-x.

Full description at Econpapers || Download paper

2021The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan. (2021). Zhang, Ying ; Song, Yanna ; Harigai, Masayoshi ; Sasaki, Nobuhito ; Khan, Nasser ; Kameda, Hideto ; Tanaka, Yoshiya ; Yamaoka, Kunihiro ; Takeuchi, Tsutomu. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:6:d:10.1007_s40264-021-01067-x.

Full description at Econpapers || Download paper

2021A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs. (2021). Manzo, Claudia ; Lacivita, Cynthia ; Toyserkani, Gita A ; Kesselheim, Aaron S ; Woloshin, Steven ; Chin, Kristyn ; Avorn, Jerry ; Feldman, William B ; Bykov, Katsiaryna ; Huybrechts, Krista F ; Mitra-Majumdar, Mayookha ; Gagne, Joshua J ; Sarpatwari, Ameet ; Dal, Gerald J ; Pinnow, Ellen ; Zhou, Esther H. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:7:d:10.1007_s40264-021-01070-2.

Full description at Econpapers || Download Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders. (2021). , Peter ; PEter, ; Hoes, Arno W ; McGettigan, Patricia ; Berg, Marijke H ; Vries, Sieta T ; Jonker, Carla J. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:8:d:10.1007_s40264-021-01081-z.

Full description at Econpapers || Download paper

2021Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessme. (2021). , Sabine ; Dogne, Jean-Michel ; Inoubli, Adrien ; Morales, Daniel R ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:44:y:2021:i:9:d:10.1007_s40264-021-01096-6.

Full description at Econpapers || Download paper

Recent citations received in 2020

YearCiting document
2020Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand. (2020). Harrison-Woolrych, Mira ; Vohra, Sunita ; Harmark, Linda ; Dong, Christine Yang ; Sheridan, Jane L ; Barnes, Joanne. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00963-y.

Full description at Econpapers || Download paper

2020Real-World Data on Bleeding Risk and Anticoagulation in Patients with IPF Treated with Antifibrotics. (2020). Kalluri, Meena ; Bendstrup, Elisabeth. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00991-8.

Full description at Econpapers || Download paper

2020Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines. (2020). Praet, Nicolas ; Begaud, Bernard ; Nachbaur, Gaelle ; Bauchau, Vincent ; Salvo, Francesco ; Bollaerts, Kaatje ; Arlegui, Hugo. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00984-7.

Full description at Econpapers || Download paper

2020Direct Oral Anticoagulants and Interstitial Lung Disease: Emerging Clues from Pharmacovigilance. (2020). Poluzzi, Elisabetta ; Diemberger, Igor ; Fusaroli, Michele ; Raschi, Emanuel. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00990-9.

Full description at Econpapers || Download paper

2020Liver Injury Associated with the Selective Progesterone Modulator Ulipristal. (2020). Bjornsson, Einar S. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:12:d:10.1007_s40264-020-01004-4.

Full description at Econpapers || Download paper

2020An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System. (2020). Muoz, Monica A ; Dal, Gerald J ; Kortepeter, Cindy M ; Jones, Christopher S ; Marwitz, Kathryn. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00908-5.

Full description at Econpapers || Download paper

2020A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study. (2020). Toutain, Pierre-Louis ; Montastruc, Jean-Louis. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:7:d:10.1007_s40264-020-00955-y.

Full description at Econpapers || Download paper

2020Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment. (2020). Shakir, Saad ; Roy, Debabrata ; Dhanda, Sandeep ; Denyer, Jacqueline ; Evans, Alison ; Lane, Samantha ; Davies, Miranda ; Osborne, Vicki. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:8:d:10.1007_s40264-020-00966-9.

Full description at Econpapers || Download paper

2020Thromboembolism and Janus Kinase Inhibitors. (2020). Scott, David L ; Ibrahim, Fowzia. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:9:d:10.1007_s40264-020-00973-w.

Full description at Econpapers || Download paper

2020The Evolving Field of Risk Communication. (2020). Besley, John ; McComas, Katherine ; Balogway, Dominic. In: Risk Analysis. RePEc:wly:riskan:v:40:y:2020:i:s1:p:2240-2262.

Full description at Econpapers || Download paper